What is the current Vascular Closure Device (VCD) Market size?

The Vascular Closure Device (VCD) Market is projected to register a CAGR of 6.82% during the forecast period (2024-2029) Read More

Who are the key players in Vascular Closure Device (VCD) Market?

Cardinal Health, Abbott Laboratories, Cardiva Medical Inc., Terumo Corporation and Biotronik SE & Co. KG are the major companies operating in the Vascular Closure Device (VCD) Market. Read More

Which is the fastest growing region in Vascular Closure Device (VCD) Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Vascular Closure Device (VCD) Market?

In 2024, the North America accounts for the largest market share in Vascular Closure Device (VCD) Market. Read More

What years does this Vascular Closure Device (VCD) Market cover?

The report covers the Vascular Closure Device (VCD) Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Vascular Closure Device (VCD) Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Vascular Closure Device (VCD) Market Share

Statistics for the 2023 & 2024 Vascular Closure Device (VCD) market share, created by Mordor Intelligence™ Industry Reports. Vascular Closure Device (VCD) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Vascular Closure Device (VCD) Industry

This market is expected to witness lucrative growth due to a high level of competitive rivalry, which translates to high revenue generation in this sector. The prominent players in this market are involved in developing novel VCDs and, in turn, broadening their product portfolios. Acquisition and collaboration with small companies to enhance presence are also expected to propel growth in this vertical. The major players in the market are Abbott Laboratories, Cardinal Health Inc., Biotronik SE & Co. KG, Cardinal Health Inc., CardivaMedical Inc., and Terumo Corporation.